Come up with a name for your new list and we'll add to it:
Global Blood Therapeutics raised a round of funding on June 14, 2012. Investors include
Third Rock Ventures.
Global Blood Therapeutics (GBT) is a biopharmaceutical company developing novel small molecule therapeutics for the treatment of severe blood disorders. The company is addressing serious, non-malignan…